Scientific American’s Worldview 100 ranks two UC Davis faculty among the top 100 visionaries in biotechnology.
“The visionaries who continue to reshape biotechnology—and the world”
At just 40 years old, biotechnology is a relatively new industry. Its starting point, arguably, was the 1975 Asilomar Conference on Recombinant DNA, at which the potential benefits and hazards of DNA manipulation and the ways it should be regulated were debated and essentially decided upon…Here, we name 100 of the industry’s leading lights in a list we’ve dubbed “The Worldview 100.” The honorees include researchers who provided fundamental insights into biological processes, as well as their colleagues who developed those insights to create the biology-based goods and services that are the essence of biotechnology…
Director | World Food Center | University of California, Davis | Davis, California, U.S.
This plant biologist visionary and founding president of the Danforth Center knows how to keep things in perspective. “After a series of laboratory successes that followed the discovery of disease-resistant technologies, I self-assuredly referenced ‘being on a roll,’” he told Worldview. “Soon thereafter I took a fall and a long roll down a run at the Purgatory ski resort at a Keystone Conference. To my chagrin and embarrassment, a friend, Jonathan Jones, from the John Innes Center, UK, shouted, ‘Are you still on a roll, Beachy?’—not just one time, but repeatedly in following years.”
Director | Laboratory for Crop Genetics Innovation & Scientific Literacy | University of California, Davis | Davis, California, U.S.
When Worldview asked Ronald to tell us her greatest contribution to biotechnology, she pointed out her work with rice, in particular, “isolation of the Xa21 resistance gene and the Sub1 submergence tolerance gene in collaboration with my colleagues.” Her pick for the most exciting application of biotech in the past year: the HIV and Ebola vaccines.
Colleagues from UCSF and UCB
Director | Institute of Computational Health Sciences | University of California, San Francisco | San Francisco, California, U.S.
Discussing the new institute, Butte notes, “We hope that we will be successful in making discoveries and developing diagnostics and therapeutics. If we want to change the world of medicine, we have to bring those discoveries into the marketplace and closer to patients.”
Li Ka Shing Chancellor’s Professor in Biomedical & Health Sciences | University of California | Berkeley, California, U.S.
One of the leading researchers who created the CRISPR-Cas9 technology for genome engineering, Doudna believes that we must “increase connections and communications between academic labs and companies” to help biotechnology move ahead even faster.